SCHEMBL21556239

SCHEMBL21556239

CC1=C(C)C(=O)N(Nc2cc(C(C)(F)F)c3ccccc3n2)C1=O

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
XPO1 O14980 4/20 0.41
ALDH1A1 P00352 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
BACE1 P56817 1/20 0.37
SLC2A1 P11166 1/20 0.36
MAPT P10636 2/20 0.35
CASP3 P42574 1/20 0.35
PDE10A Q9Y233 3/20 0.35
KDM4E B2RXH2 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
CCNE2 O96020 2/20 0.34
CDK4 P11802 2/20 0.34
CCND1 P24385 2/20 0.34
CCNE1 P24864 2/20 0.34
CDK2 P24941 2/20 0.34
HPGD P15428 1/20 0.34
GAA P10253 1/20 0.34
ELANE P08246 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1592871 0.91 BACE1 (0.47) XPO1ALDH1A1L3MBTL1BACE1SLC2A1
SCHEMBL21556198 0.79 XPO1 (0.44) XPO1
SCHEMBL13906932 0.78 SMN1; SMN2 (0.42) XPO1ALDH1A1L3MBTL1BACE1MAPT
SCHEMBL1592872 0.75 BACE1 (0.46) XPO1ALDH1A1L3MBTL1BACE1KDM4E
SCHEMBL8138653 0.71 XPO1 (0.61) XPO1ALDH1A1MAPTPDE10AKDM4E
SCHEMBL1592460 0.70 XPO1 (0.47) XPO1CDK2
SCHEMBL21556185 0.69 XPO1 (0.44) XPO1MAPTSMN1; SMN2HPGD
SCHEMBL1592486 0.68 XPO1 (0.48) XPO1ALDH1A1L3MBTL1
SCHEMBL18197816 0.68 XPO1 (0.46) XPO1
SCHEMBL1592489 0.68 XPO1 (0.45) XPO1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3567035-A1 N-SUBSTITUTED 2,5-DIOXO-AZOLINE COMPOUNDS FOR USE IN THE TREATMENT OF CANCER Canbas Co. Ltd. (JP) 2019-11-13 EP disclosed